SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-18-013333
Filing Date
2018-11-30
Accepted
2018-11-30 17:17:06
Documents
2
Period of Report
2018-11-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3895
2 ex24lalwani.txt EX-24 3900
  Complete submission text file 0001179110-18-013333.txt   9274
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3891 RANCHERO DRIVE, SUITE 150 C/O ESPERION THERAPEUTICS, INC. ANN ARBOR MI 48108
Business Address
Lalwani Narendra D. (Reporting) CIK: 0001615012 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35986 | Film No.: 181211994